Predicting mortality and no-reflow in STEMI patients using epicardial adipose tissue

Area of Science:

• Cardiology
• Medical Imaging
• Clinical Research

Background:

• Acute myocardial infarction (MI) is a primary cause of global mortality.
• ST-segment elevation myocardial infarction (STEMI) signifies severe coronary artery disease due to arterial occlusion.
• Primary percutaneous coronary intervention (PCI) is the standard reperfusion therapy for STEMI.

Purpose of the Study:

• To investigate the association between epicardial adipose tissue (EAT) thickness and adverse outcomes in STEMI patients.
• To determine if EAT thickness predicts the no-reflow phenomenon and mortality post-primary PCI.

Main Methods:

• 113 STEMI patients undergoing primary PCI were evaluated.
• Epicardial adipose tissue (EAT) thickness and left ventricular ejection fraction were assessed via echocardiography.
• Patients were stratified into two groups based on EAT thickness: <5 mm (Group I) and >5 mm (Group II).

Main Results:

• Epicardial fat thickness showed a significant correlation with the no-reflow phenomenon during catheterization.
• Increased EAT thickness was associated with poorer overall prognosis in STEMI patients.
• A cutoff of 5 mm EAT thickness was identified using ROC curve analysis.

Conclusions:

• Elevated EAT thickness may independently predict no-reflow and mortality in STEMI patients.
• Echocardiographic measurement of EAT thickness offers valuable prognostic information.
• EAT thickness serves as a potential biomarker for risk stratification in STEMI.